Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency
about
Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivoClassical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical rolesWishing away inflammation? New links between serotonin and TNF signalingPsychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesA Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in MiceReflex control of immunityReturn of the lysergamides. Part II: Analytical and behavioural characterization of N(6) -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)PsychedelicsEvidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis.Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in miceClinical applications of hallucinogens: A review.Modulation of inflammatory response in a cirrhotic rat model with induced bacterial peritonitisSustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literatureEffects of fluoxetine and escitalopram on C-reactive protein in patients of depression.Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice.Serotonin 5-HT₂ receptor activation prevents allergic asthma in a mouse modelType I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosusSerotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17)The reduction of CSF tumor necrosis factor alpha levels in schizophrenia: no correlations with psychopathology and coincident metabolic characteristics.Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.Psychedelics as Medicines: An Emerging New Paradigm.The Effects of Hallucinogens on Gene Expression.The Effects of Serotonin in Immune Cells.Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis.Development of Fluorescent Probes that Target Serotonin 5-HT2B Receptors.Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMTRapid Iododeboronation with and without Gold Catalysis: Application to Radiolabelling of Arenes.Cane Toad Skin Extract-Induced Upregulation and Increased Interaction of Serotonin 2A and D2 Receptors via Gq/11 Signaling Pathway in CLU213 Cells.Maternal hematopoietic TNF, via milk chemokines, programs hippocampal development and memory.Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process.A New Venue of TNF Targeting.Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy
P2860
Q21132497-CD1A410E-302B-41A1-9C20-A99526F59A77Q22241778-2CF8B08F-46BB-4CD3-8B19-41CDF47E3D67Q24630595-68FFAB57-6E53-403D-A185-58DC0AC613B0Q26799997-BD4A398F-1CB9-4888-B50E-B2652029BB85Q27303855-0BA625CF-02B7-4DB6-9F9B-C0604FF355E8Q28245909-2E7A218D-DF06-4D99-884A-D369071BEFCBQ28276150-2962CB99-6C5F-4A18-B05C-482EB1A2F577Q30359998-32F92A21-B89E-4CC9-BB7F-59150E9D9601Q34329315-26943C89-926E-460E-B8CB-9EF7065A9D7DQ34513881-1EBECC3D-664A-4A37-AB1D-21E771FE584FQ34535259-D9D2EDEB-E114-422B-889C-6895B2847E12Q34635442-140DBF23-2CAB-42D4-8DE8-D57185767355Q34769962-8205277C-15BB-4B76-B73B-3C3AC7053F0BQ35052329-DE1E9483-07AC-4767-A210-E31B6C30AD7CQ35092757-97419D78-A69D-452F-8D14-357CD6AD64E1Q35115841-B32FFA9B-C464-4B8B-9AD6-FD6A3C97E5DCQ35512674-525D415E-4121-471C-8065-B00666ADEA4AQ35630432-E222AC30-42CB-4353-B13B-D10465CDFC0BQ37398379-BE104BA2-B792-4F19-B1CF-B9F9072ACA3FQ37464848-08215106-5A55-4BA8-8AC2-02171ECC3594Q39055247-FC44640C-2348-4325-A8FB-498A6DCC6B22Q39414457-56414969-0B5C-4307-864B-385587A3BD45Q41061403-F407DA31-D52D-45E5-9E63-4029EA5FD3D4Q41368300-0DF501F7-7D7B-427D-A1C8-B49633BA5CEFQ41538383-62FEE1EA-129B-4A92-B13B-E165C291B49BQ42373861-3BF7E163-FC3B-41DC-808D-5D5AC2B508C1Q47378538-B4C6BE54-AAE5-4A1C-A465-F7944EBB6C02Q48682603-88AF1737-F8D6-4292-8B7A-4A779669750AQ48831588-8A0BF0A7-6BBC-4EEB-AE5C-DA0A1FB0E26CQ52318138-4C3834A3-9E5F-4880-92EF-62C0DF77181FQ55001725-0D882140-6A10-45DD-B0E8-CECFEC34866AQ56530996-64206D23-AD24-44A9-873F-2EA72CB60545
P2860
Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@ast
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@en
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@nl
type
label
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@ast
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@en
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@nl
prefLabel
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@ast
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@en
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@nl
P2093
P3181
P356
P1476
Serotonin 5-hydroxytryptamine( ...... ion with extraordinary potency
@en
P2093
A Hamid Boulares
Bangning Yu
Charles D Nichols
Jaime Becnel
Mourad Zerfaoui
Rasika Rohatgi
P304
P3181
P356
10.1124/JPET.108.143461
P407
P577
2008-11-01T00:00:00Z